Press Releases

eClinical Solutions Welcomes Sean Lannan as Chief

Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth

Abzena Announces Establishment of Scientific Advisory Board to Support Innovation Strategy

CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™, Award-Winning GenAI Platform

CapeStart announced a major new release of MadeAi™, its GenAI-based platform that expedites the synthesis of content and data for the life sciences. The platform and the MadeAi-LR solution for systematic literature review (SLR) help time-strapped teams to advance the pace of scientific research.

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

This major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials.

Inizio Evoke Supercharges Creative Leadership with Dual ECD Appointments

ELRIG Announces Keynote Speakers for Drug Discovery 2025

• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach

GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development

GenNext® Technologies, Inc. is collaborating with Thermo Fisher Scientific to provide a simplified structural biology workflow designed to improve biotherapeutic development

Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer  

Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development

Elegen expanded it's ENFINIA cell-free gene synthesis platform with the launch of an early access program for IVT Ready DNA targeted toward RNA therapeutics, cell and gene therapies, and personalized cancer vaccines. ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use to speed genetic medicine development.

GeneFab and RegCell Announce Strategic Partnership to Advance Autoimmune Cell Therapy into U.S. Clinical Trials

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development

Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies, supporting the development of more targeted treatment decisions and advancing pharmaceutical R&D.

Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services

Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.

Emmes Groups' OptymEdge to launch the first dedicated ophthalmology clinical trial platform at ARVO 2025

Symbiosis Honoured with Prestigious King’s Award for Enterprise for International Trade

Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Viz.ai Launches Viz 3D CTA™ to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making

New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.

EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery

EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.

Aplos Analytics Expands Cloud-Based Platform to Include Custom Outputs

Aplos NCA includes new features to support custom data processing, flexible table and figure creation, and the ability to create custom reports using user-defined templates.

Mundipharma announces availability of REZZAYO® (rezafungin) for adult patients with invasive candidiasis following Health Service Executive reimbursement agreement1